CARR vs. GSK
CARR (Carrier Global Corporation) and GSK (GlaxoSmithKline plc) are both stocks. CARR operates in Building Products & Equipment (Industrials), while GSK operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, CARR returned 10.28%/yr vs 5.34%/yr for GSK. At a 0.20 correlation, their price movements are largely independent.
Performance
CARR vs. GSK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CARR achieves a 33.35% return, which is significantly higher than GSK's 9.89% return.
CARR
- 1D
- 0.24%
- 1M
- 8.10%
- YTD
- 33.35%
- 6M
- 33.09%
- 1Y
- -0.12%
- 3Y*
- 16.03%
- 5Y*
- 10.28%
- 10Y*
- —
GSK
- 1D
- 0.34%
- 1M
- 6.78%
- YTD
- 9.89%
- 6M
- 10.40%
- 1Y
- 34.50%
- 3Y*
- 19.84%
- 5Y*
- 5.34%
- 10Y*
- 5.35%
CARR vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
CARR Carrier Global Corporation | 33.35% | -21.57% | 20.26% | 41.47% | -22.68% | 45.31% | 176.86% |
GSK GlaxoSmithKline plc | 9.89% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | 1.15% |
Correlation
The correlation between CARR and GSK is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 3, 2020 | 0.20 |
Fundamentals
CARR:
$58.92B
GSK:
$108.04B
CARR:
$1.55
GSK:
£2.85
CARR:
45.24
GSK:
13.90
CARR:
0.67
GSK:
0.93
CARR:
2.73
GSK:
2.47
CARR:
4.27
GSK:
3.42
CARR:
$21.87B
GSK:
£32.78B
CARR:
$5.43B
GSK:
£23.87B
CARR:
$3.15B
GSK:
£11.30B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CARR vs. GSK — Risk / Return Rank
CARR
GSK
CARR vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Carrier Global Corporation (CARR) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CARR | GSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.14 | ||
| Sortino ratioReturn per unit of downside risk | -1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.20 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | -0.05 | 1.58 | -1.63 |
| Martin ratioReturn relative to average drawdown | -0.08 | 3.92 | -4.00 |
Loading charts...
Drawdowns
CARR vs. GSK - Drawdown Comparison
The maximum CARR drawdown since its inception was -40.82%, smaller than the maximum GSK drawdown of -55.70%. Use the drawdown chart below to compare losses from any high point for CARR and GSK.
Loading charts...
Drawdown Indicators
| CARR | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.82% | -55.70% | +14.88% |
Max Drawdown (1Y)Largest decline over 1 year | -37.38% | -18.63% | -18.75% |
Max Drawdown (3Y)Largest decline over 3 years | -37.91% | -28.46% | -9.45% |
Max Drawdown (5Y)Largest decline over 5 years | -40.82% | -50.10% | +9.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -50.10% | — |
Current DrawdownCurrent decline from peak | -13.13% | -11.92% | -1.21% |
Average DrawdownAverage peak-to-trough decline | -14.21% | -18.87% | +4.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.10% | 8.28% | +15.82% |
Volatility
CARR vs. GSK - Volatility Comparison
Carrier Global Corporation (CARR) has a higher volatility of 12.13% compared to GlaxoSmithKline plc (GSK) at 6.81%. This indicates that CARR's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CARR | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.13% | 6.81% | +5.32% |
Volatility (6M)Calculated over the trailing 6-month period | 27.68% | 18.49% | +9.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.29% | 27.06% | +8.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.90% | 25.08% | +6.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.83% | 22.89% | +11.94% |
Dividends
CARR vs. GSK - Dividend Comparison
CARR's dividend yield for the trailing twelve months is around 1.65%, less than GSK's 3.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CARR Carrier Global Corporation | 1.65% | 1.70% | 1.16% | 1.30% | 1.54% | 0.94% | 0.74% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GSK GlaxoSmithKline plc | 3.26% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
Financials
CARR vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Carrier Global Corporation and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CARR vs. GSK - Profitability Comparison
CARR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Carrier Global Corporation reported a gross profit of 1.24B and revenue of 5.34B. Therefore, the gross margin over that period was 23.3%.
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a gross profit of 5.75B and revenue of 7.63B. Therefore, the gross margin over that period was 75.4%.
CARR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Carrier Global Corporation reported an operating income of 259.00M and revenue of 5.34B, resulting in an operating margin of 4.9%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported an operating income of 2.29B and revenue of 7.63B, resulting in an operating margin of 30.1%.
CARR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Carrier Global Corporation reported a net income of 238.00M and revenue of 5.34B, resulting in a net margin of 4.5%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a net income of 1.74B and revenue of 7.63B, resulting in a net margin of 22.8%.
Frequently Asked Questions
CARR and GSK have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CARR has higher volatility (12.13%) compared to GSK (6.81%). In terms of maximum drawdown, CARR dropped -40.82% vs GSK's -55.70%.
GSK currently has the higher Sharpe Ratio (1.09 vs -0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CARR and GSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer